Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial.
about
Biopsy versus resection for the management of low-grade gliomasBiopsy versus resection for the management of low-grade gliomasResection probability maps for quality assessment of glioma surgery without brain location biasIntegration of epidemiology, immunobiology, and translational research for brain tumorsEffect of neoadjuvant temozolomide upon volume reduction and resection of diffuse low-grade glioma.The role of initial chemotherapy for the treatment of adults with diffuse low grade glioma : A systematic review and evidence-based clinical practice guideline.The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.The role of surgery in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.Efficacy of Procarbazine, Lomustine, and Vincristine Chemotherapy for Recurrent Primary Central Nervous System LymphomasApplication of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group.Intraoperative diffusion tensor imaging predicts the recovery of motor dysfunction after insular lesions.Central nervous system cancersPractice changing mature results of RTOG study 9802: another positive PCV trial makes adjuvant chemotherapy part of standard of care in low-grade glioma.Biopsy versus resection for the management of low-grade gliomas.Current treatment of low grade gliomasInduction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement.Supratentorial gliomas in eloquent areas: which parameters can predict functional outcome and extent of resection?Comparing high-resolution microscopy techniques for potential intraoperative use in guiding low-grade glioma resections.Indications for Treatment: Is Observation or Chemotherapy Alone a Reasonable Approach in the Management of Low-Grade Gliomas?Laser Ablation vs Open Resection for Deep-Seated Tumors: The Case for Open Resection.Accumulation of 2-hydroxyglutarate is not a biomarker for malignant progression in IDH-mutated low-grade gliomasChanges in presentation, treatment, and outcomes of adult low-grade gliomas over the past fifty yearsRandomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802.Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02.Pre-operative clinical factors predict progression-free survival and tumor recurrence after initial surgery in patients with astrocytomas: A single-center analysis.Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis.Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy.Cognitive function testing in adult brain tumor trials: lessons from a comprehensive review.Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers.Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1.'Low grade glioma': an update for radiologists.Management of diffuse low-grade gliomas in adults - use of molecular diagnostics.Surgical Considerations in the Optimal Management of Patients with Malignant Brain Tumors.Intraoperative image guidance in neurosurgery: development, current indications, and future trendsOutcomes in Reoperated Low-Grade Gliomas.Low-grade Glioma Surgery in Intraoperative Magnetic Resonance Imaging: Results of a Multicenter Retrospective Assessment of the German Study Group for Intraoperative Magnetic Resonance Imaging.Stereotactic interstitial brachytherapy for the treatment of oligodendroglial brain tumors.Association of Surgical Approach and Margin Status With Oncologic Outcomes Following Gross Total Resection for Sinonasal Melanoma.Biomarkers in NOA-04: another piece to the puzzle.
P2860
Q24197750-87B5895E-67AC-4AEF-8F0D-B34C37D53157Q24234687-BF44003E-4E07-4F73-AC2C-8BD9217B98C0Q27307939-B2FD2F35-C016-43AD-A2BF-D5C0051B0B21Q28397886-811AAD9E-A223-46A6-9CFE-CD9EFB8F05CDQ30458648-1270213B-44D9-40D0-900D-E1CC982FE0C1Q31016193-4AA2DFB4-52BD-4582-9300-7F0D658C1027Q31016200-D4B9EE97-9F5D-44C1-BD6C-EC5A9A1F73C4Q31016208-4F3DDA25-03FE-402D-BA03-0F92A4B87820Q33427856-D6488CC4-BAE8-4043-9A90-98BCCBE15803Q33905155-E1C302A8-C51A-446E-9C83-AE70856EF5ADQ33937615-E8EEE9BC-22C8-4AF4-8C13-3CE42E2C052AQ34014740-9F67A79A-7A1A-4759-95BB-F0EE505BF471Q34511752-57281907-7ABD-44AF-B350-0891AD20A997Q34555925-2B1E78CB-9438-47C2-B1EB-D04D5DF8AA65Q34830708-CC0A412A-22FD-4FC9-8793-51D849C1BDDAQ34979511-41495753-172B-4EAE-AA5B-D1993F754B64Q35004672-A3A607E9-5481-456E-872C-6886ED573353Q35067372-D946BDA3-A5F0-40E4-8956-C4DA1638AD0CQ35601053-11051704-84D0-420B-850F-AFDCF7AFBCADQ36037100-F64F4EC9-45D4-4DC0-8A70-B60B7E929D76Q36072596-1D0FC85B-81C9-435F-83BD-3CCDFAD782D0Q36865995-6ABEF4D2-C8E0-4678-B0B3-BB1215F3776FQ37021579-935751C3-04C2-496C-9770-89B56632FCB9Q37065952-DC95975B-5590-46EF-A734-160E437DB4A5Q37570420-1635E335-83F5-4993-8334-7D4FCBEC28BAQ37639650-9D44477F-8059-4F43-BC04-BAFC6F7734B6Q37820417-3B7A1B4C-B4EF-4B00-8501-798C7EACDB68Q37987088-88A4FC1F-AFA5-44A8-95CB-312763E29D6CQ38010804-C2F27BA6-5B52-48A0-A713-808F10A5A0CCQ38480437-3BD4D2D7-2A5D-443B-9043-4708B24480C9Q38627095-F1EC4321-0984-408A-B688-74F605AECC39Q39031402-8D031059-E079-42CC-82DB-1C52532CF635Q39301977-55215A77-C6ED-4A13-B62E-45CF5D76D918Q39417263-24BEAA25-0F73-451E-9291-B7B7611A9E00Q39609081-667A2A36-4966-4CD6-9D25-0950B90C6CD2Q41104618-4844D19C-A805-4E64-91CD-C7A0822958EDQ41169134-243538BC-52DE-4156-B67D-E933C37180FEQ41452073-C673D5E7-7267-4B64-899E-87B5EA138D9FQ42697894-B85B96E0-B3EE-4B4A-A263-0262550A7502Q42702334-F84E5A12-BE80-4333-9E0A-276D4CD3C9D0
P2860
Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Recurrence following neurosurg ...... a prospective clinical trial.
@en
Recurrence following neurosurg ...... a prospective clinical trial.
@nl
type
label
Recurrence following neurosurg ...... a prospective clinical trial.
@en
Recurrence following neurosurg ...... a prospective clinical trial.
@nl
prefLabel
Recurrence following neurosurg ...... a prospective clinical trial.
@en
Recurrence following neurosurg ...... a prospective clinical trial.
@nl
P2093
P2860
P356
P1476
Recurrence following neurosurg ...... a prospective clinical trial.
@en
P2093
Brian Berkey
David Brachman
Dennis Bullard
Edward G Shaw
Geoffrey R Barger
Jan C Buckner
Keith J Stelzer
Mark R Gilbert
Minesh Mehta
Paul D Brown
P2860
P304
P356
10.3171/JNS/2008/109/11/0835
P577
2008-11-01T00:00:00Z